EMPIRICAL BAYES ESTIMATES OF SUBGROUP EFFECTS IN CLINICAL-TRIALS

被引:28
|
作者
DAVIS, CE [1 ]
LEFFINGWELL, DP [1 ]
机构
[1] BURROUGHS WELLCOME CO,DEPT CLIN STAT,RES TRIANGLE PK,NC 27709
来源
CONTROLLED CLINICAL TRIALS | 1990年 / 11卷 / 01期
关键词
Empirical Bayes estimates; subgroup effects;
D O I
10.1016/0197-2456(90)90030-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
At the completion of a clinical trial it is often desirable to compare the treatments within subgroups of patients. The results of the subgroup analysis are usually reported for the subgroups within which sizable treatment differences are found. This practice can lead to an overestimate of the difference between treatments within the subgroups reported. One way of adjusting for this bias is to use empirical Bayes methods which shrink the extreme estimates toward the overall measure of treatment difference. Both point and interval estimates can be obtained. The computations are illustrated with an example using subgroup data from the Lipid Research Clinics Coronary Primary Prevention Trial. © 1990.
引用
收藏
页码:37 / 42
页数:6
相关论文
共 50 条
  • [41] MONITORING LATE EFFECTS OF THERAPY IN CLINICAL-TRIALS
    HERSON, J
    STRONG, LC
    [J]. CONTROLLED CLINICAL TRIALS, 1981, 2 (01): : 81 - 81
  • [42] Investigating Subgroup Effects in Randomized Clinical Trials
    Dehbi, Hakim-Moulay
    Hackshaw, Allan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (02) : 253 - +
  • [43] Comparison of Interaction and Subgroup Effects in Observational Studies and Randomized Clinical Trials: Three Empirical Examples
    Schmidt, Amand F.
    Rovers, Maroeska M.
    Klungel, Olaf H.
    Hoes, Arno W.
    Knol, Mirjam J.
    Nielen, Mirjam
    de Boer, Antonius
    Groenwold, Rolf H. H.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 127 - 127
  • [44] THE IMPACT OF TECHNOLOGY ON CLINICAL-TRIALS - THE CLINICAL-TRIALS COMPUTER-SYSTEM
    TRAPILO, TC
    FRIEDMAN, RH
    [J]. PSYCHOPHARMACOLOGY BULLETIN, 1984, 20 (01) : 59 - 63
  • [45] DESIGN OF CLINICAL-TRIALS - APPROACHES TO CLINICAL-TRIALS DESIGN - OPEN DISCUSSION
    SHEINER, L
    CHALMERS, T
    VOLBERDING, P
    PECK, C
    TEMPLE, R
    JAMES, J
    LIETMAN, P
    HARRINGTON, M
    KILLEN, J
    WITTES, R
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1990, 3 : S37 - S39
  • [46] CLINICAL-TRIALS FOR COMMUNICATION AIDS - A STUDY PROVOKED BY THE CLINICAL-TRIALS OF SPLINK
    ENDERBY, P
    HAMILTON, G
    [J]. INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH, 1981, 4 (02) : 181 - 195
  • [47] Empirical Bayes models of Poisson clinical trials and sample size determination
    Zaslavsky, Boris G.
    [J]. PHARMACEUTICAL STATISTICS, 2010, 9 (02) : 133 - 141
  • [48] PHARMACODYNAMIC ANALYSIS OF ANALGESIC CLINICAL-TRIALS USING EMPIRICAL-METHODS
    LIU, CY
    SAMBOL, NC
    [J]. PHARMACEUTICAL RESEARCH, 1995, 12 (03) : 438 - 445
  • [49] ETHICS OF CLINICAL-TRIALS
    WING, JK
    [J]. JOURNAL OF MEDICAL ETHICS, 1975, 1 (04) : 174 - 175
  • [50] ASSESSING CLINICAL-TRIALS
    SPODICK, DH
    [J]. BRITISH MEDICAL JOURNAL, 1981, 283 (6283): : 64 - 65